Holding company (GNBT) with Subsidiary (NGIO) merg
Post# of 36537
Since NuGenerex is Generex’s only asset, perhaps a merger would not be a bad move (in the long run). However, regardless of which direction it would go, NGIO into GNBT or GNBT into NGIO, it would still require a shareholder vote.
NGIO into GNBT would pass a vote since GNBT owns a majority stock, GNBT into NGIO would require our approval.
If NGIO would go into (merge) with GNBT, what would we get as stockholders? There is no set NGIO pps and since GNBT is the holding/majority company, they could set the NGIO stock value. So right now, how many GNBT shares would we get for a $.0013 (NUGX) NGIO share?
If GNBT would go into (merge) with NGIO, how many NGIO untradeable (privately own company) shares of NGIO/NUGX? shares would we get for our GNBT shares?
In either case, the rogue NUGX mess really needs to be cleaned up first. And if GNBT is to merge into NGIO, NuGenerex better be trading on NASDAQ to have any value for its stockholders. Which will require an IPO.
So, I don’t know where this prediction https://finance.yahoo.com/news/world-immuno-o...00401.html came from, but before we get all excited that this could be the answer, let take a long look at reality.